JILL · J.Jill
Conviction · Low · more likely to lag the S&P 500 over the next three months
Wrong if: a daily close above $25.63
Note written ·
Price against the kill line
12.8% clear of its kill line on the 13 November 2026 close.
How to read this
This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.
The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.
The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides
Three months against the kill line
Daily closes, to . Red: the kill line, a daily close above $25.63, on record since 11 November 2026. The shares are up 20.0% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.
Kill line
A daily close above $25.63, which is over the 2 October 2026 intraday high of $25.14 and would show the shares leading the S&P 500. Third-quarter sales above the $158.054 million top of the guide would also show it.
Research onlyNot in the portfolio.
Key figures from the filings · Consumer Discretionary
Quarter to 1 August 2026, filed 9 September 2026; valuation at the 13 November 2026 close
- Revenue, latest quarter ($M)
- 155
- Revenue, change on a year (%)
- +0.5
- Gross margin (%)
- 76.8
- Operating margin (%)
- 15.7
- Free cash flow, four quarters ($M)
- 48.6
- Net cash, cash less debt ($M)
- 4.4
- Price to earnings (×)
- 12.2
- Enterprise value to sales (×)
- 0.6
All filed numbers
What J.Jill reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .
| Quarter to | Revenue ($M) | On a year (%) | Gross margin (%) | Operating margin (%) |
|---|---|---|---|---|
| first filed | 155 | +0.5 | 76.8 | 15.7 |
| first filed | 144 | −6.0 | 68.3 | 6.1 |
| first filed | 138 | −3.1 | 63.1 | −0.1 |
| first filed | 151 | −0.5 | 70.9 | 9.9 |
| first filed | 154 | −0.8 | 68.4 | 10.9 |
| first filed | 154 | −4.9 | 71.8 | 12.4 |
| Pre-tax income ($M) | 23.5 |
| Net income ($M) four quarters: 27.1 | 16.8 |
| Diluted shares, change on a year (%) against the quarter to 2 August 2025 | −1.5 |
| Operating cash flow ($M) | 65.4 |
| Capital spending ($M) | 16.8 |
| Free cash flow ($M) | 48.6 |
| Cash and short-term investments ($M) | 76.9 |
| Debt ($M) non-current long-term debt plus current maturities | 72.5 |
| Net cash, cash less debt ($M) | 4.4 |
| Deferred revenue ($M) −2.1% on a year | 6.1 |
| Backlog, orders not yet delivered ($M) 0.0% on a year | 0.4 |
| Receivables ($M) | 5.9 |
| Inventory ($M) | 52.6 |
| Shareholders' equity ($M) | 140 |
| Market value ($M) | 332 |
| Enterprise value, market value plus net debt ($M) | 328 |
| Enterprise value to sales (×) | 0.6 |
| Enterprise value to operating income (×) | 6.9 |
| Price to earnings (×) | 12.2 |
| Price to book value (×) | 2.4 |
| Free-cash-flow yield (%) | 14.6 |
Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 5.2% of shares outstanding sold short, 3.5 days of average trading to cover, −15.3% since the previous report.
| Window | Bought | Sold |
|---|---|---|
| 90 daysfrom | $0 | $1.7M |
| 12 monthsfrom | $0 | $1.7M |
The thesis
J.Jill's earnings recovery is largely reflected in the price, so the shares lean toward lagging the S&P 500 until the third-quarter report shows whether guided sales growth of 3%–5% arrives. The report is expected around 9 December 2026; the company has not yet announced the date.
The shares closed at $22.29 on 11 November 2026, 11.3% below the 52-week intraday high of $25.14 set on 2 October 2026. They are up 18.3% over three months and below the 50-day average of $23.4. The 200-day average is $17.29. MarketBeat's average analyst target was $24.50 on 19 October 2026, with two Buy and five Hold ratings.
The company has reported no results since the 9 September 2026 second-quarter release. The earnings beat is well known. Sales growth is the open question: second-quarter comparable sales rose only 0.5%, and the third-quarter guide asks for 1%–3%. TowerBrook Capital Partners' 49.4% stake remains registered for resale.
Bullish and bearish views on J.Jill, Inc.
The bull case on J.Jill, Inc. (JILL), in brief: second-quarter profit far above estimates. The bear case: controlling holder can sell at market.
Bull case
- Second-quarter profit far above estimates. Benzinga reported on 9 September 2026 that adjusted earnings per share of $1.24 beat a $0.57 estimate. Sales of $154.829 million beat a $151.260 million estimate. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $32.8 million, a 21.2% margin, per the company's 8-K.
- Full-year outlook raised. On 9 September 2026 the company guided fiscal 2026 net sales from flat to up 2%, adjusted EBITDA of $75 million–$80 million and free cash flow of about $40 million.
- Third-quarter guidance implies acceleration. The company guided third-quarter sales up 3%–5% ($155.044 million–$158.054 million per Benzinga), comparable sales up 1%–3% and adjusted EBITDA of $20 million–$22 million. A result at the top of that range would show the recovery reaching sales.
- Balance sheet carries net cash. The 9 September 2026 release showed $76.9 million of cash against $71.2 million of long-term debt. The company repurchased 99,902 shares for $1.5 million in the quarter.
- Analyst targets moved up after the beat. TD Cowen raised its target to $25 from $22 with a Hold rating on 5 October 2026, per Benzinga. MarketBeat's lowest published target was $23 on 19 October 2026.
Bear case
- Controlling holder can sell at market. The 16 September 2026 Form S-3 registers 7,338,933 shares held by a TowerBrook entity. That is 49.4% of the 14,862,977 shares outstanding on 9 September 2026.
- TowerBrook has sold before. In June 2024 a TowerBrook affiliate sold 1,300,000 shares at $31.00 in an offering that included 1,000,000 new company shares, per Paul, Weiss, which advised the seller.
- The company can issue shares too. The same 16 September 2026 filing registers up to 5,000,000 new J.Jill shares for issuance from time to time.
- Chief financial officer keeps selling. Mark Webb, EVP, CFO and COO, sold 5,000 shares at $24.52 on 19 October 2026, per a Form 4 filed 21 October 2026, under a Rule 10b5-1 plan (a pre-set selling schedule). MarketBeat reported an earlier 25,000-share sale at an average $23.28 on 21 September 2026 under the plan adopted 22 June 2026.
- Second-quarter margin was flattered. Gross margin was 76.8%, or 68.3% excluding a $13.3 million net pre-tax tariff-refund benefit, against 68.4% a year earlier, per the company's 8-K.
- Little room to the highest target. The highest published target was $25 on 19 October 2026, which is above the 11 November 2026 close of $22.29 but equal to the 52-week high zone the shares failed to hold in October.
Price setup
The shares closed at $22.29 on 11 November 2026. They closed at $23.65 on 4 November 2026 and at $22.57 on 10 November 2026, so the November drift is lower from a level near the 50-day average of $23.4.
The 52-week intraday high is $25.14, set on 2 October 2026. The 52-week closing low is $11.00, on 7 April 2026. The 200-day average of $17.29 sits well under the price, which keeps the six-month trend upward.
Closes of $22.39 on 6 November 2026 and $22.29 on 11 November 2026 are below $23, the lowest target on MarketBeat's 19 October 2026 list. The shares have therefore moved under the range analysts set after the September report. The next scheduled test is the third-quarter report; no earnings date is confirmed.
Catalysts ahead
- ~25 November 2026 (est.): Company announcement of the third-quarter results date. Last year's date was announced on 26 November 2025 for a 10 December 2025 report, so the notice fixes when the guided sales acceleration is tested.
- ~9 December 2026 (est.): Third-quarter fiscal 2026 results. It shows whether sales reach $155.044M–$158.054M, comparable sales grow at least 1% and adjusted EBITDA lands at $20M–$22M.
What would change the view
A daily close above $25.63, which is over the 2 October 2026 intraday high of $25.14 and would show the shares leading the S&P 500. Third-quarter sales above the $158.054 million top of the guide would also show it.
What it trades with
J.Jill sells women's apparel through stores and online, so it trades with mid-priced discretionary retail and consumer-spending data. It has a thin float: TowerBrook holds 49.4% of the 14,862,977 shares outstanding, and resale-registration news can move the shares independently of the sector. Tariff costs and refunds affect gross margin directly, as the second-quarter $13.3 million refund benefit showed.
The evidence, claim by claim (8)
- Q2 FY2026 adjusted EPS $1.24 vs $0.57 estimate; sales $154.829M vs $151.260M estimate Benzinga, 9 September 2026 · as of
- Q2 gross margin 76.8%, or 68.3% excluding a $13.3M net pre-tax tariff-refund benefit, vs 68.4% a year earlier J.Jill Q2 2026 results, Form 8-K Exhibit 99.1 · as of
- Q3 FY2026 guidance: sales +3% to +5%, comparable sales +1% to +3%, adjusted EBITDA $20M–$22M J.Jill Q2 2026 results, 9 September 2026 · as of
- Cash $76.9M vs long-term debt $71.2M at Q2 end; 99,902 shares repurchased for $1.5M in the quarter J.Jill Q2 2026 results, Form 8-K Exhibit 99.1 · as of
- S-3 registers up to 7,338,933 TowerBrook-held shares for resale, 49.4% of 14,862,977 outstanding, plus up to 5,000,000 primary shares SEC Form S-3 filed 16 September 2026 · as of
- CFO Mark Webb sold 5,000 shares at $24.52 on 19 October 2026 under a Rule 10b5-1 plan SEC Form 4 filed 21 October 2026 · as of
- TD Cowen raised its price target to $25 from $22 and kept a Hold rating Benzinga, 5 October 2026 · as of
- Average analyst target $24.50, range $23–$25; two Buy and five Hold ratings MarketBeat JILL analyst page, 19 October 2026 · as of
Sources
- J.Jill Inc. to Report Third Quarter Fiscal Year 2025 Results on December 10 2025 · secure.businesswire.com ·
- JILL 2Q26 Earnings Transcript · s21.q4cdn.com
Related · shared themes
ARHS
Arhaus
Arhaus's furniture orders are running far ahead of deliveries, giving the shares a modest edge over the S&P 500: Q3 2026 comparable written…
CVNA
Carvana
Carvana is taking share in a flat used-car market, with third-quarter retail units up 39% and more units guided for the fourth quarter. The…
FIGS
FIGS
FIGS, the healthcare-apparel maker, holds a modest edge over the S&P 500 after beating third-quarter estimates and raising its 2026 outlook…
OLLI
Ollie's Bargain Outlet Holdings
Ollie's Bargain Outlet shares are modestly more likely than not to beat the S&P 500, supported by a $500 million buyback and three analyst…
See also · stocks to watch